baber/WOPTO huggingface dataset:
Patent CA-2552763-A1 (CA)
Inventor: COOK MARK E
IPC: A61K31/201
Filed: 2004-11-23
Abstract: A method for treating diseases and conditions caused by type III  hypersensitive reactions in a human or non-human animal is disclosed. The method involves administering to the animal a conjugated linoleic acid (CLA) or a substance which can be converted to CLA in the animal in an amount effective to reduce inflammation in the animal.
Patent CA-2556934-A1 (CA)
Inventor: DEMPSEY JAMES F
IPC: A61N5/10
Filed: 2005-02-17
Abstract: A device and a process for performing high temporal- and spatial-resolution MR  imaging of the anatomy of a patient during intensity modulated radiation therapy (IMRT) to directly measure and control the highly conformal ionizing radiation dose delivered to the patient for the treatment of diseases caused by proliferative tissue disorders. This invention combines the technologies of open MRI, multileaf-collimator or compensating filter-based IMRT delivery, and cobalt teletherapy into a single co-registered and gantry mounted system.
Patent CA-2557345-A1 (CA)
Title: Supported catalyst comprising delta- or theta-modified aluminium oxide supports
Inventor: STEPHAN JUERGEN
IPC: C07C5/333
Filed: 2005-02-24
Abstract: The invention relates to a method for producing a supported catalyst, consisting of at least 75 wt. % Al2O3, whose delta- or theta-modified fraction of Al2O3 is at least 1 % of the total Al2O3 fraction and which contains a rhenium compound and optionally a promoter as the active component (A).  According to the invention: a) a modified support (T) is produced from a conventional support (T) consisting of at least 75 wt. % of Al2O3, to which a promoter is optionally applied, the delta- or theta-modified fraction of the Al2O3 being at least 1 % of the total Al2O3 fraction, by the calcination of the conventional support (T) at a temperature of between 750 and 1100 ~C; b) a supported catalyst precursor is produced from the modified support (T) by the application of the active component comprising the rhenium compound (A) to the modified support (T); and c) the supported catalyst precursor is calcinated at a temperature of between 500 and 750 ~C.
Patent CA-2557402-A1 (CA)
Title: Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
Inventor: VOSS EDGAR
IPC: C07D413/12
Filed: 2005-03-04
Abstract: Objects of the present invention are the compounds of formula I-A (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
Patent CA-2558520-A1 (CA)
Title: Serum-free suspension culture system for mesenchymal progenitor cells
Inventor: ZANDSTRA PETER
IPC: C12N5/02
Filed: 2005-03-04
Abstract: Non-hematopoietic, e.g., mesenchymal progenitor cells, are expanded under non-static, non-adherent conditions in serum-deprived medium.
Patent CA-2560352-A1 (CA)
Title: High-throughput automated cellular injection system and method
Inventor: WANG WENHUI
IPC: C12M3/00
Filed: 2006-09-21
Abstract: A fully automated cell injection system and method are described, which can perform automatic, reliable, and high-throughput cell injection of foreign genetic materials, proteins, and other compounds. The system and method overcome the problems inherent in traditional manual injection that is characterized by poor reproducibility, human fatigue, and low throughput. The present invention is particularly suited for zebrafish embryo injection but can be readily extended to other biological injection applications such as mouse embryo, drosophila embryo, and C.  elegans injections, capable of facilitating high-throughput genetic research at both academic and industry levels.
Patent CA-2562125-A1 (CA)
Title: Closed circuit tv security system
Inventor: BRUNETTI SAM
IPC: H04N7/18
Filed: 2005-04-05
Abstract: A closed circuit television system (10) includes a plurality of cameras (C1-Cn) installed throughout an area along routes (R1-Rn) followed by someone passing through the area. A touch screen monitor (18) displays camera images (SC). A console 12 operator selects which camera's image to display. The camera selected is a camera observing a person or object in a path by which the person or object is moving through the area. A tracking system (30) is responsive to the operator for selecting one or more additional cameras positioned along the routes the person or object would follow in moving from their current location. The monitor also displays images from each of these other selected cameras. The tracking system allows the operator to change the selection of cameras whose images are displayed in response to the route, and changes in route, as well as to initiate recording of the camera imagery.
Patent CA-2563026-A1 (CA)
Title: Method for analyzing n-terminal protein adducts
Inventor: RYDBERG PER
IPC: G01N/
Filed: 2005-04-13
Abstract: The present invention provides a method for analyzing adducts in a fluid and/or a solid material suspected of containing said adducts by bringing said material in contact with an isothiocyanate reagent containing a fluorescent.  Said reagent do not have the isothiocyanate group directly bound to an unsubstituted phenyl or pentafluorophenyl group. It also provides a method for manufacturing a standard material for use in said analyzing method. It also provides a standard material obtainable by said manufacturing method. It also provides compounds suitable for use as standard material and also use of a standard material. It also provides a container for use when analyzing adducts in a fluid or a solid material suspected of containing said adducted compounds. It also provides a method for analyzing hazardous substances.  Further it also provides a kit comprising standard material or a compound set out above. It also provides an apparatus for performing the analyzing method.  Further it also provides a computer program stored on a data carrier for performing the analyzing method or the manufacturing method set out above.
Patent CA-2563613-A1 (CA)
Inventor: CHU WEI-SING
IPC: G01N1/31
Filed: 2005-04-15
Abstract: The present invention provides a non-destructive macromolecules extraction (NDME) device for extracting high quantity of biological molecules (including, but not limited to, proteins, DNA, and/or RNA) from tissue specimens (including, but not limited to, fresh or fixed tissue sections, homogenized tissues, and cell cultures), while preserving the morphology and antigenicity of the tissue. The device contains a base, a slide cover, and a thermal control device. The tissue specimen is placed onto the base. The slide cover is mounted to the base to form a space where an extraction solution can be added. The device optionally contains a chamber cover over the slide cover.  The chamber cover and the slide cover forms a reaction chamber where a steam is infused to maintain the humidity of the tissue. The extraction solution contains a detergent. The present invention also provides a method for extracting the same.
Patent CA-2568818-A1 (CA)
Title: Methods and apparatuses for assembling a gas turbine engine
Inventor: ZIGAN DAVID CHRISTOPHER
IPC: F01D25/28
Filed: 2006-11-23
Abstract: A method for assembling a gas turbine engine (13) includes coupling an axisymmetric structure within the gas turbine engine, wherein the axisymmetric structure includes a plurality of mounting bushings (112, 114) extending from a radially outer surface of the axisymmetric structure, inserting a first quantity of fixed pins (200) at least partially into a respective mounting bushing to facilitate securing the axisymmetric structure within the gas turbine engine, and inserting a second quantity of floating pins (210) at least partially into a respective mounting bushing to facilitate each floating pin moving in both an axial and tangential direction with respect to a gas turbine engine centerline axis (34).
Patent CA-2570143-A1 (CA)
Title: Self-curling sleeve
Inventor: BAER ANGELA L
IPC: D03D15/567
Filed: 2005-07-20
Abstract: A substrate including a plurality of monofilaments, or a combination of monofilaments and multi-filament yarns oriented in perpendicular directions, has a tendency to curl around a central space. When all monofilaments are used, the monofilaments along one direction may have a larger diameter than the monofilaments along the other direction. The monofilaments are woven such that the larger diameter monofilaments form floats predominantly on one side of the substrate. For the monofilament-multifilament combination the monofilaments form floats predominantly on one side of the substrate. The substrate curls about an axis parallel to the monofilaments forming the floats. The side having the floats faces outwardly away from the central space. Preferably, the monofilaments are oriented in the warp direction along the substrate. The filaments may be woven in a herringbone twill weave, a double cloth herringbone twill weave or a satin weave to provide the floats.
Patent CA-2570389-A1 (CA)
Title: Treatments comprising strontium for rheumatic and arthritic diseases and pain
Inventor: HANSEN CHRISTIAN
IPC: A61K33/24
Filed: 2005-06-17
Abstract: Improved treatments of joint diseases, such as, e.g. osteoarthritis and rheumatoid arthritis, and pain, wherein a strontium-containing compound is administered alone or in combination with one or more second therapeutically and/or prophylactically active substances, selected from the group consisting of bisphosphonates, glucosamine, pallitative agents, analgesic agents, disease modifying anti-rheumatic compounds (DMARDs), selective estrogen receptor modulators (SERMs), aromatase inhibitors, non-steroidal anti-inflammatory agents (NSAIDs), COX-2 inhibitors, COX-3 inhibitors, opioids, inhibitors/antagonists of IL-1, inhibitors/antagonists of TNF-.alpha., inhibitors of matrix metallo-proteinases (MMPs), cathepsin K inhibitors, inhibitors/antagonists of RANK-ligand, statins, glucocorticoids, chondroitin sulphate, NMDA receptor antagonists, inhibitors of interleukin-I converting enzyme, Calcitonin gene related peptide antagonists, glycine antagonists, vanilloid receptor antagonists, inhibitors of inducible nitric oxide synthetase (iNOS), N-acetylcholine receptor agonists, neurokinin antagonists, neuroleptic agents, PAR2 receptor antagonists and anabolic growth factors acting on joint tissue components. Pharmaceutical compositions comprising a strontium-containing compound and a second therapeutically and/or prophylactically active substance as defined above.
Patent CA-2571038-A1 (CA)
Inventor: YALVAC SELIM
IPC: C09J123/10
Filed: 2005-06-28
Abstract: Compositions and methods for improving the adhesion of a film to a nonwoven, a film to another film, or a nonwoven to another nonwoven are disclosed. Depending on the laminate or multilaminate structure, the improvement can be achieved by using low viscosity, low density ethylene- or propylene-based polymers, which physically anchor to the substrate, such as a porous nonwoven, or by using a similar polymer in a blend with one of the substrate film polymers to improve flow and adhesion.
Patent CA-2571323-A1 (CA)
Title: Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Inventor: GUESSREGEN STEFAN
IPC: C07D401/06
Filed: 2005-07-25
Abstract: The invention relates to products of formula (I): in which p = 0, 1 and 2; A =  aryl, heteroaryl, carbocycle or heterocycle; X = single bond; -N(R6)-; -NH-alk-; alkylene; -O-; -C(O)-; -S(O)n-; -N(R6)-C(O)-; -NH-CO-alk-, -N(R6)-C(O)-N(R6')-; -N(R6)-C(S)-N(R6')-; -N(R6)-C(O)O-; -N(R6)-SO2-; -N(R6)-SO2-N(R6')-; -C(O)-N(R6)-; -SO2-NR6-; and -C(O)O-; L1 = single bond, alkylene, alkenylene, alkynylene, cycloalkylene, phenylene, heteroarylene; all optionally substituted; R1 = hydrogen, alkyl, alkenyl, alkynyl or cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl; -SO2R9, -C(O)R9; -C(O)OR9,-C(O)NR10R11, -C(S)NR10R11,-SO2NR10R11; R2 = hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, either R1 and R2 with N, or NR1R2 with L1 may form a saturated or unsaturated heterocycle possibly containing O, N, S; R3 = hydrogen; halogen;  alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, alkylenedioxy, heterocycle, aryl and heteroaryl, all optionally substituted; S(O)n-alkyl; amino, alkylamino, dialkylamino, with dialkylamino optionally forming with N a cycle, all optionally substituted; R4, R4' and R4''= hydrogen, halogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, oxo; with two from among R4, R4' and R4'' possibly forming with C a ring possibly containing O, N or S; L2 = single bond, alkylene, alkenylene, alkynylene, cycloalkylene, -O-, -NR17-, -C(O)-, SO2; Y = N-heterocycle possibly containing O, N or S; R5 = hydrogen, halogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl; all these radicals being optionally substituted, these products being in all the isomeric forms and the salts, as medicinal products.
Patent CA-2572386-A1 (CA)
Title: System and method for processing composite trading orders at a client
Inventor: NOVIELLO JOSEPH C
IPC: G06Q30/00
Filed: 2006-12-20
Abstract: An apparatus tor processing a composite trading order comprises an interfac e operable to display a composite value representing a weighted quantity of a plurality of trading products. The apparatus further comprises a processor operable to receive at least one input representing a composite trading order, wherein the at least one input comprises a quantity that is equal to at least a portion of the weighted quantity. The at least one input is usable to generate one or more constituent trading orders that, when filled, combine to satisfy the composite trading order.
Patent CA-2572957-A1 (CA)
Title: Protective garment ensemble
Inventor: CULLER GREGORY D
IPC: A62B17/00
Filed: 2005-07-11
Abstract: A protective garment ensemble comprising a suit having arm-receiving and leg-receiving portions, a hood portion and an opening adjacent the hood opening through which the suit can be donned and doffed and which mates with a removable face portion, the ensemble having mating fastener components around the suit opening and the face portion to form a seal between the suit and the removable face portion.
Patent CA-2573705-A1 (CA)
Title: Pharmaceutical multilayer tablet for controlled release of active ingredients with highly ph-dependent solubility
Inventor: BRUEL JEAN-LUC
IPC: A61K9/24
Filed: 2005-07-25
Abstract: The present invention relates to a pharmaceutical controlled release multilayer tablet comprising at least two layers, at least one active ingredient with highly pH-dependent solubility, at least one pharmaceutically acceptable pH maintaining excipient and at least one pharmaceutically acceptable matrix forming excipient, characterized in that said at least one active ingredient with highly pH-dependent solubility and said at least one pharmaceutically acceptable pH maintaining excipient are respectively comprised in at least one distinct layer.
Patent CA-2574507-A1 (CA)
Inventor: PRIETO VALTUENA JESUS
IPC: C07K14/475
Filed: 2005-06-21
Abstract: The invention relates to the use of amphiregulin in the production of a medicament which can be used to treat acute hepatic injury and which is administered, for example, in order to: promote a primary endogenous protective reaction in the hepatic tissue against acute hepatic injury, promote DNA synthesis in hepatocytes, prevent the death of hepatocytes in the hepatic tissue of patients with acute hepatic injury, stimulate the regeneration of the remaining hepatic parenchyma following an acute hepatic injury of any aetiology, and stimulate hepatic regeneration following a partial hepatectomy. According to the invention, the amphiregulin is administered as a hepatoprotector medicine for patients with acute hepatic injury of any aetiology and/or as a hepatoprotector medicine and stimulant of hepatocytic regeneration for recipients of a liver transplant from a living donor or a cadaver donor.
Patent CA-2576570-A1 (CA)
Title: Programmer protection method and apparatus for use with a movable barrier operator
Inventor: FITZGIBBON JAMES J
IPC: G05B19/04
Filed: 2007-02-01
Abstract: When a movable barrier operator detects (101) a predetermined state with respect to a remote transmitter learning mode, the movable barrier operator can respond by temporarily requiring (103) at least a first programmer protection duration of time to pass before permitting the movable barrier operator to respond to a remote transmitter-sourced barrier movement control signal. By one approach this first programmer protection duration of time is longer than a loss-of-signal detection duration as characterizes the movable barrier operator.
Patent CA-2582755-A1 (CA)
Inventor: ZAHURANEC TERRY L
IPC: E03D11/16
Filed: 2007-03-21
Abstract: A closet flange includes a body having a lower body portion containing a bore and an upper body portion containing an inlet opening in fluid communication with the bore. Within the body is a knockout for closing off the bore. The knockout has a frangible connection with an interior wall of the body and one or more portions that extend radially outwardly into a portion of the inlet opening that has a larger diameter than the bore to permit the knockout to be broken out of the body while preventing the knockout from passing all the way through the bore.
Patent CA-2583160-A1 (CA)
Title: Personal care compositions comprising visible beads, cationic polymer, and surfactant
Inventor: MIYAMOTO HIDEKI
IPC: A61K8/92
Filed: 2005-10-14
Abstract: Personal care compositions comprise visible beads, cationic polymer, and surfactant. The visible beads in the personal care compositions can be utilized to provide an aesthetically pleasing appearance to the product. The visible beads can also be utilized to encapsulate and deliver skin benefit agents to the skin or hair. The visible beads can also encapsulate materials that are otherwise incompatible with the personal care composition matrix to preserve product stability.
Patent CA-2583221-A1 (CA)
Inventor: BROKER MICHAEL
IPC: A61K39/295
Filed: 2005-10-07
Abstract: The present invention relates to the combination of antigens directed against bacteria and viruses, their uses and the preparation of medicaments in order to confer protection against infectious diseases. In particular, the invention relates to a combination vaccine comprising at least one antigen of Clostridium tetani, at least one antigen from Corynebacterium diphtheriae, and at least one antigen from the TBE-flavivirus suitable to confer seroprotection against diseases and medical conditions caused by these pathogenic organisms.
Patent CA-2584978-A1 (CA)
Title: Reinforcing strip for supporting reinforced earth wall and its placement method
Inventor: LEE JEUNG SU
IPC: E02D29/02
Filed: 2005-03-03
Abstract: Disclosed are a reinforcing strip for supporting a reinforced earth wall and a method for placing the same. A front end (F) of the reinforcing strip 10 is folded into halves and inserted into a reinforcing strip insertion groove 22 formed in a block 20 forming the surface of the reinforced earth wall so that the reinforcing strip 10 is directly connected to the earth wall construction block 20 without an anchor or an anchor pin, and a plurality of the reinforcing strips 10 are continuously or installed in a reinforced earth 50 in a zigzag shape, or individually buried under the reinforced earth 50 . When a plurality of the reinforcing strips 10 are continuously installed in the reinforced earth 50 in the zigzag shape, rear ends (R) of the reinforcing strips 10 are buried under the reinforced earth 50 under the condition that the rear ends (R) are folded into halves or are erected. A folding groove 16 is formed in a central portion of the reinforcing strip in the lengthwise direction so that the central portion of the reinforcing strip 10 has a smaller thickness than other portions of the reinforcing strip 10 , thereby allowing the front end to be folded into halves and inserted into the reinforcing strip insertion groove 22 of the block 20.
Patent CA-2585667-A1 (CA)
Inventor: LE TRONG
IPC: G06F15/00
Filed: 2007-04-19
Abstract: A virtual device residing on a terminal in a host terminal environment is provided.  The terminal is in communication with a device. The virtual device comprises a processing module operable to execute at least one action and to process information returned from at the least one executed action, a transformation module operable to transform a command into the at least one action to be executed by the processing module, and a response module operable to form a response to the command to be sent to the host based on the processed information.
Patent CA-2588099-A1 (CA)
Inventor: SPITLER JAMES
IPC: A61B17/70
Filed: 2005-10-10
Abstract: A stabilization assembly is described that stabilizes bony structures such as vertebrae. The stabilization assembly is partially formed by a poly-axial assembly which includes an anchor (500) connected to a poly axial connector assembly head (300), where the poly-axial assembly has various embodiments.  The assembly may include a slide ring (800), mounted in the head and a connector (700) mounted in the slide ring. The head may have a groove for coupling with a snap ring (1600). An extension (3001) is provided with locking means for locking its tubular body to the head. The slide ring and extension permit the connector to be used to drive the anchor into bone. The snap ring provides provisional fixation of one end of the connector in the head.
Patent CA-2588611-A1 (CA)
Title: User-controlled telecommunications system
Inventor: TODD JOHN H
IPC: H04L12/56
Filed: 2005-11-23
Abstract: Disclosed are svstems and methods that enable an end user (110, 115) to control the parameters behavior, and identity of network communications regardless of the limitations placed upon these controls by the end user's communications device or communications service provider (120) An intermediate proxy (180) resides on a telecommunications network (100) and accepts tnbound and outbound communications to and from a network communication device The intermediate proxv functions as an intermediary for network communications that occur between the network communications device and other network communications devices In this manner, the intermediate media proxy can control various features of the communications independent of limitations enacted by the end user's communications device or communications service provider.
Patent CA-2589749-A1 (CA)
Inventor: JOCHEM DAVID J
IPC: A45F3/04
Filed: 2005-12-01
Abstract: A mobile container includes a container (12), a lid (14), and belt clip (38).  The belt clip is adapted to be coupled to a belt worn by a person.
Patent CA-2594300-A1 (CA)
Inventor: HARRINGTON JOHN C
IPC: D21H21/10
Filed: 2005-12-22
Abstract: A method of improving retention and drainage in a papermaking process is disclosed. The method provides for the addition of an associative polymer, a water compatible polymer and optionally a siliceous material to the papermaking slurry. Additionally, a composition comprising an associative polymer, and a water compatible polymer and optionally further comprising cellulose fiber is disclosed.